Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
Retrieved on:
Tuesday, March 14, 2023
Health, Chemicals, Plastics, Infectious Diseases, Manufacturing, Other Health, Research, Science, History, Public sector, Rotation, Insecticide, Bill, ISIN, PDP, Mark R. Dybul, Agency, Sale, Toxicity, PQ, USAID, IVCC, IRS, Tropical medicine, Aluminium, Multimedia, Malaria, IRAC, Swiss Agency for Development and Cooperation, Development, Liverpool School of Tropical Medicine, The Global Fund to Fight AIDS, Tuberculosis and Malaria, LSTM, Unitaid, Public, PPM, Mitsui Chemicals, Fine chemical, Vaccine
VECTRONTM T500 will support the rotation of insecticides in line with best practice insecticide resistance management, which is critical to preserve the long-term efficacy of vector control tools.
Key Points:
- VECTRONTM T500 will support the rotation of insecticides in line with best practice insecticide resistance management, which is critical to preserve the long-term efficacy of vector control tools.
- VECTRONTM T500 has outstanding efficacy against malaria vector mosquitoes including strains and populations resistant to pyrethroids and some other insecticides.
- Mitsui Chemicals Agro will launch VECTRONTM T500 in sub-Saharan African countries from 2023 in line with locally required conditions of use.
- OZAWA says: “Mitsui Chemicals Agro is an R&D driven chemical company, that has been developing malaria vector control products to save human lives.